Skip to main content

Stocks To Watch:Sun Pharma gains 2%, RIL, Infosys Top Gainers,Sensex, Nifty Trade Higher

Sun Pharma Top Performer On Sensex -  Nifty Shares of Sun Pharmaceutical Industries Ltd. was the top performer on Sensex and Nifty. The stock rose as much as 3.2 per cent to Rs 430. The drugmaker’s U.S. subsidiary, Taro Pharma reported its quarterly results for the three months ended December. At 09:18 hrs Sun Pharmaceutical Industries was quoting at Rs 425.95, up Rs 10.55, or 2.54 per cent, on the BSE.



Infosys hits record high;- The stock breaks above resistance at Rs 759.8, the 50 per cent Fibonacci projection level of the uptrend from August 22, 2017 low to October 1, 2018 high. The stock was trading up 15.18 per cent this year as of the last close, compared with the broader NSE index's 0.66 per cent gains in the same period.

Opening Bell: Sensex, Nifty Trade Higher - Sensex and Nifty--opened mildly higher ahead of the RBI Monetary Policy meeting and tracking weak global cues. The Sensex is up 117 points to 37,092.18, while the Nifty is trading above the 11,050-mark. The street will be looking forward to a cut in key policy rates in today's RBI MPC meet. Sun Pharma shares zoomed by more than 2.7% to Rs 426.90 on BSE, while Tata Motors shares price jumped nearly 2% 

Rupee Update: Indian rupee is trading lower by 10 paise at 71.65 per dollar against previous close 71.55 per dollar.


Sun Pharma | Share Market | Infosys | Rupee Update
Labels:

Comments

Post a Comment

Popular posts from this blog

Stock Market News - Budget 2020 | Removal of exemptions in new tex regime to impact life insurers, MFs

A salaried professional opting for a lower rate of tax under the new regime will not be eligible for deductions, including insurance premium paid and ELSS investments. Removal of tax exemptions under Section 80C in the new tax regime could be a dampener for life insurance products as well as equity-linked savings schemes (ELSS) of mutual funds. In her Budget speech on February 1, Finance Minister Nirmala Sitharaman said a salaried professional opting for a lower tax rate under the new regime will not be eligible for deductions, including insurance premium paid and ELSS investments. “The removal of 80C benefit may pose a risk to new business volumes of life insurance companies,” said Kotak Institutional Equities in a report. Life insurance Tax exemptions are an important incentive for purchase of life insurance. To be eligible for exemption under Section 80C, the sum assured has to be 10 times the annual premium. This is part of the Rs 1.5 lakh limit under ...
13 comments
Read more

Stock Market News - Yellow metal hits fresh record high as Iran attacks US forces

On the MCX, gold contracts for February were trading higher by Rs 562, or 1.38 percent, at Rs 41,225 per 10 gram at 0920 hours. It hit a record high of 42,278 per 10 gm. India Gold February futures hit a fresh record high on January 8 tracking gains in international spot prices which surged past $1,600 an ounce mark after Iran fired rockets at Iraqi airbase which hosts US forces that triggered risk-off sentiment. Spot prices hit their highest since March 2013 at $1,610.90 earlier in the session. US gold futures rose 2 percent to $1,605.80. “The jump in the price of what’s viewed by investors as a safer asset in times of political and economic uncertainty came after Iran’s missile attack on US-led forces in Iraq early on Wednesday,” said a Reuters report. “The attack came hours after the funeral of an Iranian commander whose killing in a US drone strike has raised fears of a wider conflict in the Middle-East,” it said. On the MCX, gold contracts for February were trading...
4 comments
Read more

Stock Market News - FDC share price at 52-week high on GMP certificate from UK health regulator

The certificate came after a recent inspection of the company's facilities in Goa. FDC  share price touched a 52-week high of Rs 222, rising more than 5 percent in the morning trade on January 3 after the company received the good manufacturing practice (GMP) certificate from the UK's health regulator. The UK's Medicines and Healthcare Products Regulatory Agency also continued with its approved status for the company's two facilities in Verna, Goa. The GMP certificate was issued after a recent inspection of the two plants. At 1018 hours, FDC was quoting at Rs 218.00, up Rs 7.30, or 3.46 percent. The share price has risen 30 percent in the last three months. GNFC share price down 2% after DoT seeks Rs 15K cr in telecom dues DoT sent the company a demand notice for Rs 15,019 crore, taking to Rs 3.13 lakh crore the amount it has sought from non-telecom companies following a Supreme Court ruling. The share price of  Gujarat Narmada Valley Fertili...
3 comments
Read more